Ramy Farid
President & CEO at Schrodinger Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Schrodinger Inc., 3 years.
Schrodinger Inc.
Director · President & CEO
Structure Therapeutics Inc.
Director
Vir Biotechnology Inc.
Director
Chief executive roles
Schrodinger Inc.
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2024 | Vir Biotechnology Inc. | Grant or award | +16,000 | — | — |
| Feb 7, 2023 | Structure Therapeutics Inc. | Derivative conversion | +642,245 | — | — |
| Jan 4, 2023 | Schrodinger Inc. | Option exercise | +66,886 | $1.20 | $80,263 |
| Jan 4, 2023 | Schrodinger Inc. | Open-market sale | −66,886 | $18.28 | $1,222,676 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.